Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

C3 Complement

Complement

C3Complement component 3

Review status

Currently under review

Pending specialist review and validation.

What it shows

C3 complement is a blood test that measures the amount of complement component 3, a key protein in your immune system. C3 helps your body recognize and clear germs, damaged cells, and immune complexes. It is produced mainly by the liver and circulates in the bloodstream as part of the complement cascade.

Clinicians often check C3 together with other complement proteins to understand how your immune system is functioning. Levels can change with inflammation, certain infections, autoimmune conditions, and rare inherited complement deficiencies.

Why it matters

C3 levels can help your clinician evaluate inflammation and immune activity. In autoimmune diseases such as lupus or certain kidney conditions, C3 may decrease when the immune system is highly active and consuming complement. Low C3 can also occur with rare genetic deficiencies, which may increase susceptibility to specific infections. Higher C3 levels may be seen with acute inflammation or metabolic conditions.

This test is commonly ordered when you have signs of autoimmune disease, unexplained kidney findings, recurrent infections, or abnormal results on related tests. Tracking C3 over time can help monitor disease activity and response to treatment when used alongside your symptoms, exam findings, and other laboratory tests.

Understanding your results

Your C3 result is interpreted in the context of your history, exam, and other labs. A lower result can suggest complement consumption from active immune complex disease, infection, or a hereditary deficiency. A higher result can reflect an acute phase response or other inflammatory or metabolic states.

If results are unexpected, your clinician may repeat the test, check related markers such as C4 or total complement activity, and review medications and liver function. Follow-up can include urine and kidney assessments, autoimmune panels, or referral to a specialist. Discuss any concerns with your care team so results can be interpreted safely and accurately for your situation.

Reference ranges

0.791.52 g/L
All sexes
0 days – 18 years
0.791.52 g/L
All sexes
18 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact C3 Complement

  • Recent infection or inflammation

    Active infections and inflammatory states can change C3 levels by increasing production or driving consumption as the immune system responds.

  • Autoimmune disease activity

    Conditions like lupus and some kidney diseases may lower C3 through immune complex formation and complement activation during disease flares.

  • Liver function and nutrition

    Because C3 is made in the liver, reduced liver synthetic capacity or severe malnutrition can lower levels independent of immune activity.

  • Medications

    Immunosuppressants, biologics, and some other drugs can alter immune activity and affect C3; always tell your clinician what you take.

  • Sample handling

    Improper handling, delays in processing, or hemolysis may affect complement measurements; timely, correct processing helps ensure accuracy.

  • Genetic complement deficiencies

    Rare hereditary defects in complement proteins or regulators can cause persistently low C3 and increase risk of certain bacterial infections.

  • Hormonal and metabolic influences

    States such as pregnancy or higher body mass index may shift complement proteins as part of broader changes in inflammation and metabolism.

2026

References

  1. McGill University Health Centre. (2015, March 01). C3 Complement (Task CD 684747). Laboratory reference ranges.
  2. Aringer, M., Costenbader, K., Daikh, D., et al. (2019). 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis & Rheumatology, 71(9), 1400-1412. External link
  3. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. (2021). KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International, 100(4S), S1–S276. External link